PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.\', \'Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.\', \'Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.\', \'Internal Medicine Unit 2, Careggi University Hospital, Florence, Italy.\', \'Internal Medicine Unit 3, AOU Careggi, Florence, Italy.\', \'Internal Medicine Unit 1, Careggi University Hospital, Florence, Italy.\', \'Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Internal Medicine Unit 3, AOU Careggi, Florence, Italy.\', \'Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Microbiology and Virology Unit, Careggi University Hospital, Florence, Italy.\', \'Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy. Electronic address: alessandro.bartoloni@unifi.it.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1201-9712(21)00377-510.1016/j.ijid.2021.04.065
?:doi
?:hasPublicationType
?:journal
  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 33901656
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all